Axalta Coating Systems (AXTA) leads this week's group of expected IPOs. The list of 10 companies expected to begin trading this week is projected to raise about $2.2 billion.
Full IPO calendar HERE. In order of largest IPO first.
(1) Based in Hamilton HM 11, Bermuda, Axalta Coating Systems (AXTA) scheduled an $877 million IPO on NYSE with a market capitalization of $4.5 billion at a price range midpoint of $19.50 for Wednesday, Nov. 12, 2014.
AXTA is a leading global manufacturer, marketer and distributor of high performance coatings systems. AXTA generates approximately 90% of its revenue in markets where AXTA holds the #1 or #2 global market position, including the #1 position in its core automotive refinish end-market with approximately a 25% global market share.
(2) Based in Raleigh, NC,PRA Health Sciences (PRAH) scheduled a $400 million IPO on Nasdaq with a market capitalization of $1.2 billion at a price range midpoint of $21.50 for Thursday, Nov. 13, 2014.
PRAH is one of the world's leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries.
(3) Based in Burlingame, CA,Virgin America (VA) scheduled a $300 million IPO on Nasdaq with a market capitalization of $1 billion at a price range midpoint of $22.50 for Friday, Nov. 14, 2014.
VA is a premium-branded, low-cost airline based in California that provides scheduled air travel in the continental United States and Mexico.
(4) Based in Monte Carlo, Monaco,Navios Maritime Midstream Partners LP (NAP) scheduled a $162 million IPO on NYSE with a market capitalization of $187 million at a price range midpoint of $20 for Thursday, Nov. 13, 2014.
NAP is a growth oriented limited partnership formed to own, operate and acquire crude oil tankers under long-term employment contracts
One of NAP’s key strengths is its relationships with Navios Maritime Holdings (NYSE: NM) $60 million market cap, and Navios Maritime Acquisition (NYSE: NNA) $448 million market cap.
(5) Based in Shanghai, CHINA,eHi Car Services Ltd (EHIC) scheduled a $130 million IPO on NYSE with a market capitalization of $739 million at a price range midpoint of $13 for Friday, Nov. 14, 2014.
EHIC is the No. 1 car services provider and No. 2 car rentals provider in China in terms of market share by revenues in 2013, according to Frost & Sullivan.
The top three players in China's car rental and car service industry, including EHIC, in aggregate accounted for 10.7% of the market share by revenues in 2013, according to Frost & Sullivan.
(6) Based in San Francisco, CA,FibroGen (FGEN) scheduled a $124 million IPO on Nasdaq with a market capitalization of $975 million at a price range midpoint of $17.50 for Friday, Nov. 14, 2014.
FGEN is a research-based, biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic agents to treat serious unmet medical needs.
FGEN intends to leverage its extensive experience in fibrosis and HIF biology to build a successful biopharmaceutical company with a strong pipeline of products and product candidates for the treatment of anemia, fibrosis, cancer, corneal blindness and other serious unmet medical needs.
(7) Based in Rehovot, Israel,NeuroDerm, Ltd. (NDRM) scheduled a $65 million IPO on Nasdaq with a market capitalization of $238 million at a price range midpoint of $14.50 for Thursday, Nov. 13, 2014.
NDRM is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system, or CNS, disorders through proprietary formulations based on existing drugs that are intended to make a significant difference in patients' lives.
Product candidates in NDRM’s pipeline are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration, primarily subcutaneously or transdermally.
(8) Based in El Segundo, CA,Landmark Infrastructure Partners LP (LMRK) scheduled a $60 million IPO on Nasdaq with a market capitalization of $94 million at a price range midpoint of $20 for Friday, Nov. 14, 2014.
LMRK is a growth-oriented master limited partnership formed by Landmark to acquire, own and manage a portfolio of real property interests that it leases (triple net leases) to companies in the wireless communication, outdoor advertising and renewable power generation industries.
(9) Based in New York, NY,S1 Biopharma(SXB) scheduled a $36 million IPO on Nasdaq with a market capitalization of $119 million at a price range midpoint of $13 for the week of November 10, 2014.
SXB is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel, first-in-class therapies for sexual dysfunction.
SXB has a portfolio of four clinical and pre-clinical stage drug candidates.
(10) Based in Petach Tikva, Israel,PolyPid Ltd. (PLPD) scheduled a $20 million IPO on Nasdaq with a market capitalization of $103 million at a price range midpoint of $11 for Friday, Nov. 14, 2014.
PLPD is an emerging specialty pharmaceutical company engaged in research and development of its product candidates based on PLEX, its proprietary drug delivery technology.
PLEX (abbreviation for Polymer-Lipid Encapsulation MatriX) is able to encapsulate many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time, including periods not previously thought possible.
Read Next
